image
Healthcare - Biotechnology - NASDAQ - IE
$ 28.19
-0.564 %
$ 4.56 B
Market Cap
12.7
P/E
CASH FLOW STATEMENT
401 M OPERATING CASH FLOW
1807.21%
53.4 M INVESTING CASH FLOW
182.67%
-290 M FINANCING CASH FLOW
-18306.23%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Alkermes plc
image
Net Income 356 M
Depreciation & Amortization 74.9 M
Capital Expenditures -48 M
Stock-Based Compensation 101 M
Change in Working Capital -36.7 M
Others -6.12 M
Free Cash Flow 353 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Mar-2013 Mar-2012 Mar-2011 Mar-2010 Mar-2009 Mar-2008 Mar-2007 Mar-2006 Mar-2005 Mar-2004 Mar-2003 Mar-2002 Mar-2001 Mar-2000 Mar-1999 Mar-1998 Mar-1997 Mar-1996 Mar-1995 Mar-1994 Mar-1993 Mar-1992
OPERATING CASH FLOW
Net Income 355.8 (158.3) (48.2) (110.9) (196.6) (139.3) (157.9) (208.4) (227.2) (30.1) 25.0 (113.7) (45.5) (39.6) 130.5 167.0 9.4 3.8 (73.9) (102.4) (106.9) (61.4) (16.9) (68.0) (41.1) (9.8) (18.8) (13.7) (11.9) (17.3) (40.1) (8.1)
Depreciation & Amortization 74.9 77.9 78.7 81.9 80.4 103.7 98.5 94.3 85.6 98.1 73.8 93.7 8.7 25.0 10.3 12.1 12.0 10.9 10.6 10.9 9.3 10.5 7.7 6.4 21.6 2.7 2.6 2.4 2.2 2.8 1.5 0.6
Deferred Income Tax (99.9) (32.8) 5.1 10.0 (0.3) 10.6 7.2 (9.7) (37.6) (19.2) (2.1) (14.6) 0.8 94 K 3.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 100.9 94.3 87.6 90.2 101.0 105.4 83.9 94.4 97.3 59.6 41.3 0 28.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 6.3 27.3 4.1 (1.4) 22.2 26.4 (7.7) (7.1) (40.5) (108.1) 10.7 4.3 1.9 3.7 (1.7) (138.3) 31.7 5.9 13.2 3.7 21.3 5.8 (1.7) 30.0 0.2 (0.5) 14.5 K 0 1.5 100 K 31.2 0.8
Change in Working Capital (36.7) 12.7 (25.5) 13.1 65.4 (7.4) (4.9) (27.2) 82.0 10.9 (15.4) (1.1) 8.4 (15.4) (123.0) 1.6 30.6 95.9 (24.1) (10.5) 27.5 2.4 (7.1) (1.4) 4.9 6.5 (1.0) 5.8 (0.9) 2.3 1.4 (38.5)
Cash From Operations 401.4 21.0 101.7 82.8 72.1 99.3 19.2 (63.8) (40.4) 11.1 126.6 (2.5) (5.9) (12.2) 34.6 42.4 83.7 116.5 (74.3) (98.2) (48.7) (42.7) (18.0) (33.0) (14.2) (1.1) (17.2) (5.5) (9.1) (12.3) (6.0) (45.2)
INVESTING CASH FLOW
Capital Expenditures (48.0) (38.3) (29.0) (42.2) (90.9) (69.4) (51.3) (43.7) (52.9) (33.7) (22.2) (17.0) (9.4) (15.8) (5.5) (21.9) (36.3) (28.7) (17.8) (15.1) (46.3) (33.4) (10.0) (5.8) (24.1) (8.0) (2.2) (5.6) (0.6) (1.9) (2.5) (0.8)
Other Items 101.4 (26.3) (37.2) 30.7 (50.9) 47.2 32.9 170.9 9.4 (229.7) (45.9) (400.2) 15.0 43.8 50.9 83.9 6.2 (109.2) (21.0) (65.8) 78.1 75.5 31.2 (188.8) 28.6 (105.1) (54.6) (6.3) 6.0 10.2 4.1 (8.1)
Cash From Investing Activities 53.4 (64.5) (66.2) (11.5) (141.8) (22.2) (18.4) 127.2 (43.5) (263.4) (68.1) (417.2) 5.6 28.0 45.4 62.0 (30.1) (137.9) (38.8) (80.9) 31.8 42.1 21.2 (194.5) 4.5 (113.0) (56.8) (11.9) 5.4 8.3 1.6 (8.9)
FINANCING CASH FLOW
Common Stock Repurchased (28.5) (18.2) (16.6) (7.7) (9.3) (19.6) (16.4) (13.5) (25.9) (12.8) (11.7) 0 (3.7) 0 (2.7) (18.0) (93.3) (12.5) 0 0 0 0 0 24.9 K 0 0 0 0 0 0 0 0
Total Debt Repaid (3.0) (3.0) 20.3 (2.8) (2.8) (0.7) 0 (65.8) (6.8) (6.8) (83.5) (83.5) 443.3 (45.4) (23.5) (83.4) (1.6) (1.8) (1.1) 147.6 113.2 41.5 5.0 (5.6) (7.2) 15.6 3.1 1.7 1.8 2.0 6.1 2.0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (286.7) 1.4 8.7 0.7 9.6 (0.9) 4.1 7.6 47.6 67.1 50.1 38.4 21.5 17.3 2.8 80 K 0.1 0 0 0 (43.2) (62.6) (14.0) (7.3) (6.5) 99.8 (39.6) (59.5) 0 4.3 100 K (0.7)
Cash From Financing Activities (289.7) (1.6) 29.1 (2.2) 6.8 (1.6) 4.1 (58.2) 40.9 308.8 (45.0) 464.8 (40.7) (23.3) (94.3) (83.6) (6.7) 7.4 150.6 116.6 73.4 10.7 (3.3) 224.5 15.2 114.9 76.3 16.8 2.1 6.3 1.5 57.2
CHANGE IN CASH
Net Change In Cash 165.0 (45.1) 64.6 69.2 (63.0) 75.5 4.9 5.3 (43.0) 56.5 13.4 45.2 (40.9) (7.6) (14.3) 20.7 46.9 (13.9) 37.6 (62.6) 56.5 10.1 (0.2) (3.0) 5.4 0.7 2.4 (0.6) (1.6) 2.4 (2.9) 3.1
FREE CASH FLOW
Free Cash Flow 353.3 (17.2) 72.7 40.6 (18.9) 29.9 (32.1) (107.5) (93.2) (22.5) 104.3 (19.5) (15.3) (28.0) 29.1 20.5 47.4 87.9 (92.1) (113.4) (95.0) (76.1) (28.0) (38.8) (38.3) (9.1) (19.4) (11.1) (9.7) (14.2) (8.5) (46.0)